Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33976481

about

Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.Isolation of cancer progenitor cells from cancer stem cells in gastric cancer Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method.Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies.Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines A novel zebrafish xenotransplantation model for study of glioma stem cell invasion.The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells.ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma.Extracellular vesicles-mediated noncoding RNAs transfer in cancer.Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.The role of human aldehyde dehydrogenase in normal and cancer stem cells.Clinical implications of DNA methylation in hepatocellular carcinoma.Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.Multiple roles of CD90 in cancer.FBXL12-Mediated Degradation of ALDH3 is Essential for Trophoblast Differentiation During Placental Development.Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions.Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections.Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA).Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance.CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.

P2860

Q26822652-4726039B-5402-45B0-ABB4-D6BAE7D9BD1B Q33275167-3023FB0B-8E98-48A4-B5A8-AC32442D5496 Q33702282-BDF296B9-2AF4-4135-85F8-BCBA87DBFE91 Q33940830-E29EE907-BF4C-49D2-9132-C3F038F992DC Q34256683-3C69355A-A8D3-438E-98F2-6015C30A9E9D Q34354184-223D53FC-6C02-4505-A8FF-97AB4666342A Q34457148-7D93A30D-C763-43F4-9AC4-1C9ED2B1BB41 Q34685158-6FA691A1-48E3-496B-9214-173DC3792C00 Q35014932-1514CC1E-66F3-4205-A8A6-C29B3820D3C4 Q35600888-95FFB086-87EF-4EDF-B727-BE70243814BF Q35954464-1A88AE83-FD92-420C-9CD9-1391184499F5 Q36322395-6F57113B-8569-46F7-82F6-B8C4077803F2 Q36413028-D2BB7FDD-9009-4D8F-81D0-2C72EEB06A01 Q37100176-A8BCE6E6-9898-4BF3-AC94-5EF26090A72F Q37372279-8C856FB2-0E3A-42D9-8C04-EEAE96A2BF21 Q37582429-7640522B-8017-40A2-8DD5-4683EA17826B Q37663393-A8FB8AA4-E0EC-45E3-A1CB-CBEEAC8AE3BA Q37697137-3A98A7E0-3FDF-4103-83BE-A46778BF726B Q37811959-85FA610A-0C85-454C-B2C9-72D2E2E1372E Q37879219-BE1DF4DC-0BCD-4640-9B87-F28104FE5B94 Q37885165-76955822-0F7B-492F-A48F-AE2A1ADC51B9 Q37912492-05A53D9A-07B5-45F2-B3BB-8575F8153FC6 Q38155666-6074C3E1-31A2-4CC1-B097-C05469BEA414 Q38533025-4144B8E2-1D34-42CF-9766-5F250CF51559 Q38707438-C52C216E-FD58-4E9C-9F42-AE7249754DF0 Q38788971-B891E2BE-32E5-4902-B4E3-67B3C03C3743 Q38805813-42A63C1F-387A-4CB3-A48B-32045D0FB4AC Q38858740-AB5F46C2-ED34-4E66-BB5A-62FFAD878F01 Q38899847-7CE3A5F9-E37E-4914-8C12-3E3717F8A49F Q38953085-F208B70C-BEBD-430B-A0F0-941AB451522D Q39001423-E5DB9A7A-ED58-480D-B68C-3720B9A75246 Q39031410-F9BEE201-8F64-47BE-9FC9-FB81ECB1B86B Q39177087-E74E2D15-4516-4D30-B329-1BE914C57B28 Q40059071-D503E32B-D60B-483A-BD1B-849123997265 Q40222055-6A1EFD69-4E23-443C-AE72-5059379480C7 Q40648635-F2D6CC8D-CFBC-4C90-B5ED-A875ED9A4CC6 Q41449151-CAA7508A-E6AE-4C13-9902-E115B699E97F Q42062405-1BC94216-956F-473D-AB1E-C207E3D9A3E7 Q44372454-02B89782-6F67-4F83-B303-3FAE524C7091 Q47292629-D6900830-79E4-4899-8BB1-B7B6EF350034

P2860

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33976481

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@ast

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@en

type

label

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@ast

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@en

prefLabel

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@ast

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@en

P1433

Q33976481-0DA9EC01-AE4D-4AA2-9774-89AF2434E398

P1476

Q33976481-0765BD3D-BAED-4338-A32C-46D18C2EB059

P2093

Q33976481-1269B1E5-52E3-4E03-AE1D-CEEF42409445

Q33976481-4A43BF47-C19E-476B-9746-38D5C8B53204

Q33976481-881F03D3-3F7B-403E-97DC-FFCBF6E2D221

Q33976481-A0FFB0D7-6390-4914-BE20-9133938184A9

Q33976481-E256B2E1-5950-4829-8089-C56E103EB1A4

Q33976481-E636AAFA-988C-47C0-9DA7-91FA53A10138

Q33976481-EB9E3243-5B89-4FBB-A533-238E3DB2CE74

P2860

Q33976481-043E179D-130E-485F-8BE4-4DEF1B2F4612

Q33976481-080B633E-EB97-41AD-9EB6-E13691EFD0B8

Q33976481-22559649-5351-4906-A35A-06AF9606AB32

Q33976481-24514A52-F9FC-424D-BDAA-C9A336CE754F

Q33976481-2FC08E16-9756-485F-8888-A97ECD6190D9

Q33976481-3E4BC17C-6F84-4A80-AFBE-2B16BD0F322E

Q33976481-4E35ACF9-ADE7-47D5-8487-03F5BEE73E3D

Q33976481-547CAFB4-1F45-4D6E-BBD1-D7857A243CBE

Q33976481-554E1F28-6DAF-4E0D-91C0-8DF7AC89DB3A

Q33976481-5B61352E-D76D-435F-A14D-2BD38970EB77

P304

Q33976481-74B5BB4F-1BDE-4576-8FBC-6BDDEC23BC89

P31

Q33976481-C3F5FA44-7C4A-4F98-9D18-265BAAD8BE0B

P356

Q33976481-04C80C9D-C605-481E-8F1E-B11506FD1122

P433

Q33976481-B9DE03D4-FB12-4FE4-B17B-89BF6090C22A

P478

Q33976481-16023CAF-8BD6-42FD-B7CA-0A36991C2522

P577

Q33976481-A13459C1-A4A9-43C8-90F1-8837E6ACB5BD

P5875

Q33976481-7B175D34-A096-4869-BAD0-8DE8E7AFFC9D

P698

Q33976481-9AF4E1BD-5765-49DD-838A-AF6B73570121

P921

Q33976481-FC70FD2E-C996-4654-844B-7BCFF9672287

P932

Q33976481-0365B2E1-2594-406F-8FF9-575FCF0EB90B

P356

J.YEXMP.2010.05.005

P1433

Experimental and Molecular Pathology

P1476

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

@en

P2093

Boris H Ruebner

http://www.w3.org/2001/XMLSchema#string

Jian Wu

http://www.w3.org/2001/XMLSchema#string

Mark A Zern

http://www.w3.org/2001/XMLSchema#string

Shilpa Lingala

http://www.w3.org/2001/XMLSchema#string

Xiao-Feng Qian

http://www.w3.org/2001/XMLSchema#string

Xiaoli Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Yao Cui

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

Significance of CD90+ cancer stem cells in human liver cancer

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Cancer stem cells: models and concepts

Cancer stem cell-directed therapies: recent data from the laboratory and clinic.

Epithelial cells with hepatobiliary phenotype: is it another stem cell candidate for healthy adult human liver?

Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model.

P304

27-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YEXMP.2010.05.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44638603

http://www.w3.org/2001/XMLSchema#string

P698

20511115

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

2900434

http://www.w3.org/2001/XMLSchema#string